Daniel Ebner: Grateful to receive the Michael Pedrick Memorial Research Award from Sarcoma Foundation of America

The Michael Pedrick Memorial Research Award is a grant provided by the Sarcoma Foundation of America (SFA). The award is named in honor of Michael Pedrick, an individual who battled sarcoma, a type of cancer that occurs in the bones and soft tissues. The foundation established this award to support innovative research in the field of sarcoma, with the goal of improving treatment options and outcomes for those affected by this rare and often aggressive cancer.

The Michael Pedrick Memorial Research Award is designed to fund cutting-edge research projects focused on sarcoma. The SFA aims to accelerate the development of new therapies by supporting early-stage research, which often struggles to find funding through traditional sources.

Typically, applicants for this award include researchers, scientists, and clinicians who are engaged in sarcoma research. The specific eligibility criteria might vary from year to year, so it’s important for potential applicants to review the latest guidelines provided by the SFA.

The grant amount associated with the Michael Pedrick Memorial Research Award varies. The funding provided is intended to cover expenses directly related to the research project, including materials, personnel, and other related costs.

Daniel Ebner won this award this year.
He shared on X, saying:

“Thank you!

So grateful to receive the Michael Pedrick Memorial Research Award from Sarcoma Foundation of America for our collaborative work with The National Institutes for Quantum Science and Technology (QST).

Much more to come!”

Nadia Laack sent her congratulations:

“Congratulations Daniel Ebner! So excited for you to continue your work to understand effects of carbon ions on osteosarcoma.”

Carbon-ion radiotherapy for enhancing treatment response to osteosarcoma

Daniel Ebner is a Resident Physician at Mayo Clinic and a Clinical Researcher at the National Institutes for Quantum and Radiological Science and Technology. He also conducts research at the National Institute of Radiological Sciences (NIRS), specializing in Carbon-Ion Radiotherapy. His work focuses on identifying and advancing novel combinatorial therapies for treating glioblastoma.

Nadia Laack is the Chair of the Department of Radiation Oncology at Mayo Clinic. Her research focuses on improving radiotherapy treatment and patient outcomes, reducing toxicity in pediatric and adult brain tumors, and enhancing outcomes for pediatric and adult sarcomas, as well as skull base tumors like chordomas and chondrosarcomas.